481 related articles for article (PubMed ID: 23812456)
1. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Bristow RE; Chang J; Ziogas A; Anton-Culver H
Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
[TBL] [Abstract][Full Text] [Related]
2. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
3. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract][Full Text] [Related]
4. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
8. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
Jochum F; De Rozario T; Lecointre L; Faller E; Boisrame T; Dabi Y; Lavoué V; Coutant C; Touboul C; Bolze PA; Bricou A; Canlorbe G; Collinet P; Huchon C; Bendifallah S; Ouldamer L; Mezzadri M; Querleu D; Akladios C
Int J Gynecol Cancer; 2021 Nov; 31(11):1443-1452. PubMed ID: 34607855
[TBL] [Abstract][Full Text] [Related]
9. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
[TBL] [Abstract][Full Text] [Related]
10. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
11. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
[TBL] [Abstract][Full Text] [Related]
12. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
13. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
[TBL] [Abstract][Full Text] [Related]
14. Spatial analysis of advanced-stage ovarian cancer mortality in California.
Bristow RE; Chang J; Ziogas A; Gillen DL; Bai L; Vieira VM
Am J Obstet Gynecol; 2015 Jul; 213(1):43.e1-43.e8. PubMed ID: 25644440
[TBL] [Abstract][Full Text] [Related]
15. Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery.
Uppal S; Spencer RJ; Rice LW; Del Carmen MG; Reynolds RK; Griggs JJ
Obstet Gynecol; 2018 Jul; 132(1):126-136. PubMed ID: 29889756
[TBL] [Abstract][Full Text] [Related]
16. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.
Cliby WA; Powell MA; Al-Hammadi N; Chen L; Philip Miller J; Roland PY; Mutch DG; Bristow RE
Gynecol Oncol; 2015 Jan; 136(1):11-7. PubMed ID: 25449311
[TBL] [Abstract][Full Text] [Related]
18. Trends in hospital volume and patterns of referral for women with gynecologic cancers: adherence to treatment guidelines for ovarian cancer as a measure of quality care.
Barnett JC; Phippen NT; Leath CA
Obstet Gynecol; 2013 Oct; 122(4):905-906. PubMed ID: 24084554
[No Abstract] [Full Text] [Related]
19. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract][Full Text] [Related]
20. Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
Aviki EM; Lavery JA; Roche KL; Cowan R; Dessources K; Basaran D; Green AK; Aghajanian CA; O'Cearbhaill R; Jewell EL; Leitao MM; Gardner GJ; Abu-Rustum NR; Sabbatini P; Bach PB
Gynecol Oncol; 2020 Nov; 159(2):418-425. PubMed ID: 32814642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]